NCT07720245 Effectiveness of a Self-health Assessment Mobile Application in Young-to-midlife Adults in Hong Kong
| NCT ID | NCT07720245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Diabetes Risk |
| Study Type | INTERVENTIONAL |
| Enrollment | 574 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 574 participants in total. It began in 2024-06-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to compare the effectiveness of Wellnuts, an evidence-based, algorithm-driven self-health assessment mobile application, in empowering asymptomatic young-to-midlife adults in Hong Kong, promoting health awareness, and improving health-seeking behaviour and linkage-to-care, compared with conventional web-based health resources. Participants will be randomly allocated to the mobile health intervention group (Wellnuts app with self-health assessment and health information) and the conventional web-based resources control group (health information from Centre for Health Protection website). Hopefully, population health will be improved with the general health promotion impact from the app.
Eligibility Criteria
Inclusion Criteria: * Hong Kong residents self-reported age of 25-65 years; * Possesses a smartphone capable of running mobile apps (e.g. Android or iPhone) and; * Able to read either English or Chinese. Exclusion Criteria: * Individuals having any symptoms or feeling unwell in anyways as detailed in the Disclaimer at the launch of the app; or * Individuals reporting a current diagnosis of cardiovascular disease, lung cancer, hepatitis B, colorectal cancer, diabetes, sexually transmitted diseases, depression, anxiety and mild cognitive impairment and memory loss.
Contact & Investigator
William Chi Wai Wong, MD
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT07720245 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying Diabetes Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07720245 currently recruiting?
Yes, NCT07720245 is actively recruiting participants. Contact the research team at levon@hku.hk for enrollment information.
Where is the NCT07720245 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07720245 clinical trial?
NCT07720245 is sponsored by The University of Hong Kong. The principal investigator is William Chi Wai Wong, MD at The University of Hong Kong. The trial plans to enroll 574 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.